Global CAR T-cell Therapy Drug market growth is projected to reach  US$ 6439 million in 2025 to US$ 32570 million in 2031; it is expected to grow at a CAGR of 31.0% from 2025 to 2031.

Global CAR T-cell Therapy Drug Market Trends and Analysis 2025-31

The global CAR T-cell Therapy Drug market size is predicted to grow from US$ 6439 million in 2025 to US$ 32570 million in 2031; it is expected to grow at a CAGR of 31.0% from 2025 to 2031. Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer The CAR T-cell therapy drug gel market is driven by the revolutionary approach of CAR T-cell therapy in cancer treatment and the demand for targeted and personalized therapies. CAR T-cell therapy involves genetically modifying a patients own T cells to target and destroy cancer cells. The rise in cancer prevalence and the need for innovative treatments contribute to market growth as healthcare providers seek effective and tailored solutions for patients with difficult-to-treat cancers. Moreover, advancements in gel-based drug delivery systems have improved the precision and safety of CAR T-cell therapy administration. However, the market also faces challenges, including complex manufacturing processes and potential side effects associated with immune response. Additionally, addressing the high cost of CAR T-cell therapies and ensuring scalability and accessibility for broader patient populations can pose obstacles for manufacturers and healthcare systems. To succeed, companies must focus on advancing research and development, collaborating with oncologists to optimize therapy protocols, and addressing the challenges to meet the increasing demand for breakthrough cancer treatments. LPI (LP Information) newest research report, the CAR T-cell Therapy Drug Industry Forecast looks at past sales and reviews total world CAR T-cell Therapy Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected CAR T-cell Therapy Drug sales for 2025 through 2031. With CAR T-cell Therapy Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CAR T-cell Therapy Drug industry. This Insight Report provides a comprehensive analysis of the global CAR T-cell Therapy Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CAR T-cell Therapy Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global CAR T-cell Therapy Drug market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CAR T-cell Therapy Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CAR T-cell Therapy Drug. This report presents a comprehensive overview, market shares, and growth opportunities of CAR T-cell Therapy Drug market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; CD19-targeted &nbsp;&nbsp;&nbsp; BCMA-targeted Segmentation by Application: &nbsp;&nbsp;&nbsp; Lymphoma &nbsp;&nbsp;&nbsp; Multiple Myeloma This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Novartis &nbsp;&nbsp;&nbsp; Gilead Sciences &nbsp;&nbsp;&nbsp; Bristol-Myers Squibb &nbsp;&nbsp;&nbsp; J & J &nbsp;&nbsp;&nbsp; JW Therapeutics &nbsp;&nbsp;&nbsp; FOSUNKite

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global CAR T-cell Therapy Drug Market Size (2020-2031) &nbsp;2.1.2 CAR T-cell Therapy Drug Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for CAR T-cell Therapy Drug by Country/Region (2020, 2024 & 2031) &nbsp;2.2 CAR T-cell Therapy Drug Segment by Type &nbsp;2.2.1 CD19-targeted &nbsp;2.2.2 BCMA-targeted &nbsp;2.3 CAR T-cell Therapy Drug Market Size by Type &nbsp;2.3.1 CAR T-cell Therapy Drug Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global CAR T-cell Therapy Drug Market Size Market Share by Type (2020-2025) &nbsp;2.4 CAR T-cell Therapy Drug Segment by Application &nbsp;2.4.1 Lymphoma &nbsp;2.4.2 Multiple Myeloma &nbsp;2.5 CAR T-cell Therapy Drug Market Size by Application &nbsp;2.5.1 CAR T-cell Therapy Drug Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global CAR T-cell Therapy Drug Market Size Market Share by Application (2020-2025) 3 CAR T-cell Therapy Drug Market Size by Player &nbsp;3.1 CAR T-cell Therapy Drug Market Size Market Share by Player &nbsp;3.1.1 Global CAR T-cell Therapy Drug Revenue by Player (2020-2025) &nbsp;3.1.2 Global CAR T-cell Therapy Drug Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global CAR T-cell Therapy Drug Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 CAR T-cell Therapy Drug by Region &nbsp;4.1 CAR T-cell Therapy Drug Market Size by Region (2020-2025) &nbsp;4.2 Global CAR T-cell Therapy Drug Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas CAR T-cell Therapy Drug Market Size Growth (2020-2025) &nbsp;4.4 APAC CAR T-cell Therapy Drug Market Size Growth (2020-2025) &nbsp;4.5 Europe CAR T-cell Therapy Drug Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa CAR T-cell Therapy Drug Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas CAR T-cell Therapy Drug Market Size by Country (2020-2025) &nbsp;5.2 Americas CAR T-cell Therapy Drug Market Size by Type (2020-2025) &nbsp;5.3 Americas CAR T-cell Therapy Drug Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC CAR T-cell Therapy Drug Market Size by Region (2020-2025) &nbsp;6.2 APAC CAR T-cell Therapy Drug Market Size by Type (2020-2025) &nbsp;6.3 APAC CAR T-cell Therapy Drug Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe CAR T-cell Therapy Drug Market Size by Country (2020-2025) &nbsp;7.2 Europe CAR T-cell Therapy Drug Market Size by Type (2020-2025) &nbsp;7.3 Europe CAR T-cell Therapy Drug Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa CAR T-cell Therapy Drug by Region (2020-2025) &nbsp;8.2 Middle East & Africa CAR T-cell Therapy Drug Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa CAR T-cell Therapy Drug Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global CAR T-cell Therapy Drug Market Forecast &nbsp;10.1 Global CAR T-cell Therapy Drug Forecast by Region (2026-2031) &nbsp;10.1.1 Global CAR T-cell Therapy Drug Forecast by Region (2026-2031) &nbsp;10.1.2 Americas CAR T-cell Therapy Drug Forecast &nbsp;10.1.3 APAC CAR T-cell Therapy Drug Forecast &nbsp;10.1.4 Europe CAR T-cell Therapy Drug Forecast &nbsp;10.1.5 Middle East & Africa CAR T-cell Therapy Drug Forecast &nbsp;10.2 Americas CAR T-cell Therapy Drug Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market CAR T-cell Therapy Drug Forecast &nbsp;10.2.2 Canada Market CAR T-cell Therapy Drug Forecast &nbsp;10.2.3 Mexico Market CAR T-cell Therapy Drug Forecast &nbsp;10.2.4 Brazil Market CAR T-cell Therapy Drug Forecast &nbsp;10.3 APAC CAR T-cell Therapy Drug Forecast by Region (2026-2031) &nbsp;10.3.1 China CAR T-cell Therapy Drug Market Forecast &nbsp;10.3.2 Japan Market CAR T-cell Therapy Drug Forecast &nbsp;10.3.3 Korea Market CAR T-cell Therapy Drug Forecast &nbsp;10.3.4 Southeast Asia Market CAR T-cell Therapy Drug Forecast &nbsp;10.3.5 India Market CAR T-cell Therapy Drug Forecast &nbsp;10.3.6 Australia Market CAR T-cell Therapy Drug Forecast &nbsp;10.4 Europe CAR T-cell Therapy Drug Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market CAR T-cell Therapy Drug Forecast &nbsp;10.4.2 France Market CAR T-cell Therapy Drug Forecast &nbsp;10.4.3 UK Market CAR T-cell Therapy Drug Forecast &nbsp;10.4.4 Italy Market CAR T-cell Therapy Drug Forecast &nbsp;10.4.5 Russia Market CAR T-cell Therapy Drug Forecast &nbsp;10.5 Middle East & Africa CAR T-cell Therapy Drug Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market CAR T-cell Therapy Drug Forecast &nbsp;10.5.2 South Africa Market CAR T-cell Therapy Drug Forecast &nbsp;10.5.3 Israel Market CAR T-cell Therapy Drug Forecast &nbsp;10.5.4 Turkey Market CAR T-cell Therapy Drug Forecast &nbsp;10.6 Global CAR T-cell Therapy Drug Forecast by Type (2026-2031) &nbsp;10.7 Global CAR T-cell Therapy Drug Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market CAR T-cell Therapy Drug Forecast 11 Key Players Analysis &nbsp;11.1 Novartis &nbsp;11.1.1 Novartis Company Information &nbsp;11.1.2 Novartis CAR T-cell Therapy Drug Product Offered &nbsp;11.1.3 Novartis CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Novartis Main Business Overview &nbsp;11.1.5 Novartis Latest Developments &nbsp;11.2 Gilead Sciences &nbsp;11.2.1 Gilead Sciences Company Information &nbsp;11.2.2 Gilead Sciences CAR T-cell Therapy Drug Product Offered &nbsp;11.2.3 Gilead Sciences CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Gilead Sciences Main Business Overview &nbsp;11.2.5 Gilead Sciences Latest Developments &nbsp;11.3 Bristol-Myers Squibb &nbsp;11.3.1 Bristol-Myers Squibb Company Information &nbsp;11.3.2 Bristol-Myers Squibb CAR T-cell Therapy Drug Product Offered &nbsp;11.3.3 Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Bristol-Myers Squibb Main Business Overview &nbsp;11.3.5 Bristol-Myers Squibb Latest Developments &nbsp;11.4 J & J &nbsp;11.4.1 J & J Company Information &nbsp;11.4.2 J & J CAR T-cell Therapy Drug Product Offered &nbsp;11.4.3 J & J CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 J & J Main Business Overview &nbsp;11.4.5 J & J Latest Developments &nbsp;11.5 JW Therapeutics &nbsp;11.5.1 JW Therapeutics Company Information &nbsp;11.5.2 JW Therapeutics CAR T-cell Therapy Drug Product Offered &nbsp;11.5.3 JW Therapeutics CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 JW Therapeutics Main Business Overview &nbsp;11.5.5 JW Therapeutics Latest Developments &nbsp;11.6 FOSUNKite &nbsp;11.6.1 FOSUNKite Company Information &nbsp;11.6.2 FOSUNKite CAR T-cell Therapy Drug Product Offered &nbsp;11.6.3 FOSUNKite CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 FOSUNKite Main Business Overview &nbsp;11.6.5 FOSUNKite Latest Developments 12 Research Findings and Conclusion

Report	Global CAR T-cell Therapy Drug Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI13687

Buyer Information

Order Summary